Analysis of the ability of five adjuvants to enhance immune responses to a chimeric plant virus displaying an HIV-1 peptide

被引:38
作者
McInerney, TL
Brennan, FR
Jones, TD
Dimmock, NJ [1 ]
机构
[1] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England
[2] Axis Genet Plc, Cambridge CB2 4AZ, England
关键词
adjuvant; antibody; neutralization; HIV-1; gp41; cowpea mosaic virus; T-cell; T-helper cell response; mouse;
D O I
10.1016/S0264-410X(98)00388-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The ability of five different adjuvants (alum, complete Freund's adjuvant, Quil A, AdjuPrime and Ribi) to stimulate humoral and T-cell mediated immune responses against a purified chimeric virus particle was investigated. Each adjuvant was administered subcutaneously to adult mice together with 10 mu g of wildtype (wt) cowpea mosaic virus (CPMV) or a chimeric CPMV displaying the HIV-1 gp41 peptide, residues 731-752. All preparations elicited strong antibody responses to CPMV, but Quil A elicited the highest and most consistent responses to the HIV-I peptide. This finding was reflected in both ELISA titres with immobilized peptide and in HIV-l-neutralizing antibody. In addition Quil A was also the only adjuvant to stimulate an in vitro proliferative T-cell response. Surprisingly with all adjuvant formulations a predominately IgG2a anti-gp41 peptide response was observed, indicating a type 1 T-helper cell-like response. Furthermore, the efficiency of the CPMV display system was demonstrated by its ability to induce good levels of peptide specific antibody in the absence of any adjuvant. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1359 / 1368
页数:10
相关论文
共 39 条
  • [1] PROTECTION OF CHIMPANZEES FROM INFECTION BY HIV-1 AFTER VACCINATION WITH RECOMBINANT GLYCOPROTEIN GP120 BUT NOT GP160
    BERMAN, PW
    GREGORY, TJ
    RIDDLE, L
    NAKAMURA, GR
    CHAMPE, MA
    PORTER, JP
    WURM, FM
    HERSHBERG, RD
    COBB, EK
    EICHBERG, JW
    [J]. NATURE, 1990, 345 (6276) : 622 - 625
  • [2] THE CONTROL OF THE ANTIBODY ISOTYPE RESPONSE TO RECOMBINANT HUMAN-IMMUNODEFICIENCY-VIRUS GP120 ANTIGEN BY ADJUVANTS
    BOMFORD, R
    STAPLETON, M
    WINSOR, S
    MCKNIGHT, A
    ANDRONOVA, T
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (10) : 1765 - 1771
  • [3] MHCPEP - A DATABASE OF MHC-BINDING PEPTIDES
    BRUSIC, V
    RUDY, G
    HARRISON, LC
    [J]. NUCLEIC ACIDS RESEARCH, 1994, 22 (17) : 3663 - 3665
  • [4] The neutralizing antibody response against a conserved region of human immunodeficiency virus type 1 gp41 (amino acid residues 731-752) is uniquely directed against a conformational epitope
    Buratti, E
    McLain, L
    Tisminetzky, S
    Cleveland, SM
    Dimmock, NJ
    Baralle, FE
    [J]. JOURNAL OF GENERAL VIROLOGY, 1998, 79 : 2709 - 2716
  • [5] ENHANCEMENT OF ANTIBODY-RESPONSES TO INFLUENZA-B VIRUS HEMAGGLUTININ BY USE OF A NEW ADJUVANT FORMULATION
    BYARS, NE
    ALLISON, AC
    HARMON, MW
    KENDAL, AP
    [J]. VACCINE, 1990, 8 (01) : 49 - 56
  • [6] CLELAND JL, 1994, AIDS RES HUM RETROV, V10, pS21
  • [7] ROLE OF CYTOKINES IN THE DIFFERENTIATION OF CD4+ T-CELL SUBSETS INVIVO
    COFFMAN, RL
    VARKILA, K
    SCOTT, P
    CHATELAIN, R
    [J]. IMMUNOLOGICAL REVIEWS, 1991, 123 : 189 - 207
  • [8] VIRALLY INDUCED MODULATION OF MURINE IGG ANTIBODY SUBCLASSES
    COUTELIER, JP
    VANDERLOGT, JTM
    HEESSEN, FWA
    VINK, A
    VANSNICK, J
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (06) : 2373 - 2378
  • [9] IGG2A RESTRICTION OF MURINE ANTIBODIES ELICITED BY VIRAL-INFECTIONS
    COUTELIER, JP
    VANDERLOGT, JTM
    HEESSEN, FWA
    WARNIER, G
    VANSNICK, J
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (01) : 64 - 69
  • [10] Adjuvants - A classification and review of their modes of action
    Cox, JC
    Coulter, AR
    [J]. VACCINE, 1997, 15 (03) : 248 - 256